0000950170-24-026422.txt : 20240305
0000950170-24-026422.hdr.sgml : 20240305
20240305180014
ACCESSION NUMBER: 0000950170-24-026422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryan Barbara
CENTRAL INDEX KEY: 0001827169
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40908
FILM NUMBER: 24722904
MAIL ADDRESS:
STREET 1: 22 CAVRAY ROAD
CITY: NORWALK
STATE: CT
ZIP: 06855
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MiNK Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840229
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 212-994-8250
MAIL ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: AgenTus Therapeutics, Inc.
DATE OF NAME CHANGE: 20210112
4
1
ownership.xml
4
X0508
4
2024-03-01
0001840229
MiNK Therapeutics, Inc.
INKT
0001827169
Ryan Barbara
149 FIFTH AVENUE, SUITE 500
NEW YORK
NY
10010
true
false
false
false
false
Common Stock
2024-03-01
4
A
false
18685
0.95
A
86617
D
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
By: /s/ Christine Klaskin, Attorney-in-Fact
2024-03-05